Early surgery appears a better option than conventional management among asymptomatic patients with severe aortic stenosis (AS), according to new findings presented at the American Heart Association Scientific Sessions 2019 in Philadelphia.
FRANCE-TAVI Registry: Balloon-Expandable versus Self-Expandable TAVR on Paravalvular Regurgitation and 2-Year Mortality
Two of the most widely used transcatheter heart valves (THV) designs may not achieve the same clinical outcomes, according to new study results from the American Heart Association 2019 Scientific Sessions.
New research from the American Heart Association Scientific Sessions 2019 in Philadelphia suggest that different future trials are required to compare antiplatelets among transcatheter aortic valve replacement (TAVR) patients not requiring anticoagulation.
The daily use of colchicine significantly reduces the risk of first and total ischemic cardiovascular (CV) events compared to placebo in patients with a recent myocardial infarction (MI), according to newly presented findings from the American Heart Association Scientific Sessions 2019 in Philadelphia.
The use inclisiran reduces low-density lipoprotein (LDL-C) levels in patients with atherosclerotic cardiovascular disease (ASCVD), new study results presented at the American Heart Association 2019 Scientific Sessions suggest.